Compare Muromachi Chemicals, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 3,985 Million (Micro Cap)
9.00
NA
0.00%
0.20
16.73%
1.50
Revenue and Profits:
Net Sales:
1,895 Million
(Quarterly Results - Nov 2025)
Net Profit:
187 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
55.91%
0%
55.91%
6 Months
52.76%
0%
52.76%
1 Year
24.45%
0%
24.45%
2 Years
60.08%
0%
60.08%
3 Years
46.07%
0%
46.07%
4 Years
37.41%
0%
37.41%
5 Years
0%
0%
0.0%
Muromachi Chemicals, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
90.08%
EBIT Growth (5y)
61.29%
EBIT to Interest (avg)
19.40
Debt to EBITDA (avg)
1.19
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
1.60
Tax Ratio
31.07%
Dividend Payout Ratio
41.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.97%
ROE (avg)
16.83%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.44
EV to EBIT
7.69
EV to EBITDA
5.95
EV to Capital Employed
1.38
EV to Sales
0.58
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
17.95%
ROE (Latest)
15.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY
Nov'25
Nov'24
Change(%)
Net Sales
1,894.70
1,423.80
33.07%
Operating Profit (PBDIT) excl Other Income
320.40
105.70
203.12%
Interest
10.50
7.10
47.89%
Exceptional Items
0.20
0.00
Consolidate Net Profit
186.60
51.60
261.63%
Operating Profit Margin (Excl OI)
145.00%
47.30%
9.77%
USD in Million.
Net Sales
YoY Growth in quarter ended Nov 2025 is 33.07% vs 2.01% in Nov 2024
Consolidated Net Profit
YoY Growth in quarter ended Nov 2025 is 261.63% vs -26.91% in Nov 2024
Annual Results Snapshot (Consolidated) - May'25
May'25
May'24
Change(%)
Net Sales
6,653.00
6,369.10
4.46%
Operating Profit (PBDIT) excl Other Income
593.90
558.00
6.43%
Interest
29.00
18.50
56.76%
Exceptional Items
-77.40
47.60
-262.61%
Consolidate Net Profit
241.30
330.20
-26.92%
Operating Profit Margin (Excl OI)
65.00%
66.20%
-0.12%
USD in Million.
Net Sales
YoY Growth in year ended May 2025 is 4.46% vs 1.24% in May 2024
Consolidated Net Profit
YoY Growth in year ended May 2025 is -26.92% vs 28.83% in May 2024
About Muromachi Chemicals, Inc. 
Muromachi Chemicals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






